Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.
about
Transcriptional regulation of chemokine expression in ovarian cancerHow does the metabolism of tumour cells differ from that of normal cellsCitrate synthase expression affects tumor phenotype and drug resistance in human ovarian carcinomaRegulation of cytoskeleton organization by sphingosine in a mouse cell model of progressive ovarian cancer.Bioenergetic analysis of ovarian cancer cell lines: profiling of histological subtypes and identification of a mitochondria-defective cell line.Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.Dietary supplementation of chinese ginseng prevents obesity and metabolic syndrome in high-fat diet-fed miceOvarian tumor-initiating cells display a flexible metabolismCommon Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskBioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells.Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancerChickens from lines selected for high and low body weight show differences in fatty acid oxidation efficiency and metabolic flexibility in skeletal muscle and white adipose tissue.Fluid shear stress impacts ovarian cancer cell viability, subcellular organization, and promotes genomic instability.Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
P2860
Q26825361-58DFA99D-F9E8-4CAE-BD72-064472686A84Q27011856-E4ABB022-131B-4BA1-94D4-16CD1ED6040CQ28542897-F1FE8AFA-B1FB-4C63-90C5-222AED794AABQ33649759-3FD103A5-BAFE-482F-BCA1-64E641D15425Q33655175-9B121F2D-214B-43AA-B794-084F4D9A2BE7Q33803278-FAEE2A8C-0D64-47B8-AC9C-74858A576C98Q34652532-A25AEA3F-779F-406D-81AF-7EDC8B88B449Q34658326-19256E5C-9F53-47A9-A338-A4FFF03577DEQ35668946-E2F157A3-4E4F-46FB-84CE-EB076EBF9633Q41458947-DD9BAE22-1182-40E5-ACA0-021902D99223Q41779719-384F7219-CF54-4758-B620-05148A549ED2Q44992939-3BACEDE0-4148-48FE-B77B-F4CECA69FF8CQ55339618-F00C7B6A-B5DF-4FF3-8FCE-80E5BB6B4C2CQ58723357-4DCCB72B-0D79-40CC-BFAD-5BB72EDEB66A
P2860
Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.
@en
type
label
Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.
@en
prefLabel
Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.
@en
P2093
P2860
P1476
Metabolic changes during ovarian cancer progression as targets for sphingosine treatment
@en
P2093
Eva M Schmelz
Madlyn I Frisard
Matthew W Hulver
Paul C Roberts
Ryan P McMillan
Timothy J Brown
P2860
P304
P356
10.1016/J.YEXCR.2013.02.017
P407
P577
2013-03-19T00:00:00Z